Abbisko Cayman Ltd

Company Profile

• Business description

  Abbisko Cayman Ltd is an investment holding company that operates through its subsidiaries which is a clinical-stage biopharmaceutical company dedicated to the discovery and development of medicines and differentiated small molecule oncology therapies. The company has pipeline of 21 program candidates, with a primary focus on oncology and pimicotinib has received approval from the China NMPA, and several other candidates are currently in clinical development stage. The company has only one business segment which is the development of medicines. Geographically, the company has it's concentration in European Union and Chinese mainland region.

• Contact

  Building 3, No. 898 Halei Road
  Zhangjiang Hi-Tech Park, Pudong New Area
  Shanghai
  CHN

  T: +86 2168912098

  https://www.abbisko.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Biotechnology

  Fiscal Year End

  31 December 2026

  Employees

  276